The Cancer Control Center approves a diagnostic service to detect breast cancer, the first of its kind in the Middle East

0
86
The Cancer Control Center approves a diagnostic service to detect breast cancer, the first of its kind in the Middle East

The Kuwait Cancer Control Center of the Ministry of Health has recently approved a diagnostic service, “the first of its kind in the Middle East”, concerned with diagnosing breast cancer, its spread, and evaluating the response to hormonal therapy.

Director of the (Centre’s) Dr. Hadeel Al-Mutawa told Kuwait News Agency today that the new service that has been approved in the Nuclear Medicine Unit is based on the use of a substance known as (F18-FES), a positron-radiation material concerned with diagnosing hormone receptors for breast cancer patients.

Advertisement

Al-Mutawa explained that breast cancer ranks first as the most common type of disease locally, regionally and globally, noting that early detection increases the cure rate as well as the treatment options and effectiveness used.

His Royal Highness Prince Mohammed bin Salman

For her part, Head of the Medical Imaging Department at the center, Dr. Mashael Bandar, said that “the production of (F18-FES) is the third of the center’s cyclotron accelerator device (a device for accelerating charged particles), stressing the keenness to produce new materials to keep pace with the latest global developments. And raising the level of health and diagnostic services in the State of Kuwait.

In turn, the head of the nuclear medicine department at the center, Dr. Farida Al-Kandari, stressed to (KUNA) the importance of the new diagnostic service, as it includes diagnosing the spread of the disease, evaluating the response to hormonal therapy and the possibility of its recurrence. She explained that the material used in this service was approved by the US Food and Drug Organization, while the protocol for the examination was circulated and introductory lectures were given to specialized doctors in the center’s clinical departments.

Advertisement

For her part, Head of the Radioactive Materials Unit, Shatha Naji, indicated that the aforementioned material was successfully produced last October, and the approvals and documentation required to start production were completed, as of Thursday, for two cases in the Nuclear Medicine Unit.

Also Read: Latest Written Updates

Source: Tellyupdates

Advertisement

Leave a Reply